Literature DB >> 19020961

IGF ligand and receptor regulation of mammary development.

Anne M Rowzee1, Deborah A Lazzarino, Lauren Rota, Zhaoyu Sun, Teresa L Wood.   

Abstract

The insulin-like growth factors, IGF-I and IGF-II, have endocrine as well as autocrine-paracrine actions on tissue growth. Both IGF ligands are expressed within developing mammary tissue throughout postnatal stages with specific sites of expression in the epithelial and stromal compartments. The elucidation of circulating versus local actions and of epithelial versus stromal actions of IGFs in stimulating mammary epithelial development has been the focus of several laboratories. The recent studies addressing IGF ligand function provide support for the hypotheses that (1) the diverse sites of IGF expression may mediate different cellular outcomes, and (2) IGF-I and IGF-II are distinctly regulated and have diverse functions in mammary development. The mechanisms for IGF function likely are mediated, in part, through diverse IGF signaling receptors. The local actions of the IGF ligands and receptors as revealed through recent publications are the focus of this review.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19020961      PMCID: PMC2665296          DOI: 10.1007/s10911-008-9102-8

Source DB:  PubMed          Journal:  J Mammary Gland Biol Neoplasia        ISSN: 1083-3021            Impact factor:   2.673


  82 in total

Review 1.  Insulin-like growth factor receptors.

Authors:  P Nissley; W Lopaczynski
Journal:  Growth Factors       Date:  1991       Impact factor: 2.511

2.  Progesterone receptors in the mouse mammary duct: distribution and developmental regulation.

Authors:  G B Silberstein; K Van Horn; G Shyamala; C W Daniel
Journal:  Cell Growth Differ       Date:  1996-07

3.  Regulation of in situ to invasive breast carcinoma transition.

Authors:  Min Hu; Jun Yao; Danielle K Carroll; Stanislawa Weremowicz; Haiyan Chen; Daniel Carrasco; Andrea Richardson; Shelia Violette; Tatiana Nikolskaya; Yuri Nikolsky; Erica L Bauerlein; William C Hahn; Rebecca S Gelman; Craig Allred; Mina J Bissell; Stuart Schnitt; Kornelia Polyak
Journal:  Cancer Cell       Date:  2008-05       Impact factor: 31.743

4.  A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting.

Authors:  T M DeChiara; A Efstratiadis; E J Robertson
Journal:  Nature       Date:  1990-05-03       Impact factor: 49.962

5.  Paracrine overexpression of insulin-like growth factor-1 enhances mammary tumorigenesis in vivo.

Authors:  Krisztina Kovács de Ostrovich; Isabel Lambertz; Jennifer K L Colby; Jie Tian; Joyce E Rundhaug; Dennis Johnston; Claudio J Conti; John DiGiovanni; Robin Fuchs-Young
Journal:  Am J Pathol       Date:  2008-08-07       Impact factor: 4.307

6.  Evidence against a role for insulin-like growth factor II in the autonomous growth of rat 18,54-SF cells.

Authors:  P Nissley; L Lee; W Kiess
Journal:  Mol Cell Endocrinol       Date:  1991-03       Impact factor: 4.102

Review 7.  Insulin-like growth factor expression in breast cancer epithelium and stroma.

Authors:  K J Cullen; A Allison; I Martire; M Ellis; C Singer
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

8.  Growth factor messenger RNA expression by human breast fibroblasts from benign and malignant lesions.

Authors:  K J Cullen; H S Smith; S Hill; N Rosen; M E Lippman
Journal:  Cancer Res       Date:  1991-09-15       Impact factor: 12.701

Review 9.  Similarities and differences between insulin and IGF-I: structures, receptors, and signalling pathways.

Authors:  Haim Werner; Doron Weinstein; Itay Bentov
Journal:  Arch Physiol Biochem       Date:  2008-02       Impact factor: 4.076

Review 10.  Distinct actions of insulin-like growth factors (IGFs) on placental development and fetal growth: lessons from mice and guinea pigs.

Authors:  C T Roberts; J A Owens; A N Sferruzzi-Perri
Journal:  Placenta       Date:  2008-01-11       Impact factor: 3.481

View more
  16 in total

Review 1.  Postpartum Involution and Cancer: An Opportunity for Targeted Breast Cancer Prevention and Treatments?

Authors:  Virginia F Borges; Traci R Lyons; Doris Germain; Pepper Schedin
Journal:  Cancer Res       Date:  2020-02-19       Impact factor: 12.701

2.  Insulin-like growth factor-I receptor (IGF-IR) translocates to nucleus and autoregulates IGF-IR gene expression in breast cancer cells.

Authors:  Rive Sarfstein; Metsada Pasmanik-Chor; Adva Yeheskel; Liat Edry; Noam Shomron; Naama Warman; Efrat Wertheimer; Sharon Maor; Lea Shochat; Haim Werner
Journal:  J Biol Chem       Date:  2011-11-29       Impact factor: 5.157

3.  Decreased IGF type 1 receptor signaling in mammary epithelium during pregnancy leads to reduced proliferation, alveolar differentiation, and expression of insulin receptor substrate (IRS)-1 and IRS-2.

Authors:  Zhaoyu Sun; Sain Shushanov; Derek LeRoith; Teresa L Wood
Journal:  Endocrinology       Date:  2011-05-31       Impact factor: 4.736

4.  In Vivo Calcium Imaging Visualizes Incision-Induced Primary Afferent Sensitization and Its Amelioration by Capsaicin Pretreatment.

Authors:  Hirotake Ishida; Yan Zhang; Ruben Gomez; John Shannonhouse; Hyeonwi Son; Ratan Banik; Yu Shin Kim
Journal:  J Neurosci       Date:  2021-08-27       Impact factor: 6.167

5.  AKT regulates BRCA1 stability in response to hormone signaling.

Authors:  Andrew C Nelson; Traci R Lyons; Christian D Young; Kirk C Hansen; Steven M Anderson; Jeffrey T Holt
Journal:  Mol Cell Endocrinol       Date:  2010-01-18       Impact factor: 4.102

6.  Prolactin enhances insulin-like growth factor I receptor phosphorylation by decreasing its association with the tyrosine phosphatase SHP-2 in MCF-7 breast cancer cells.

Authors:  Kristopher C Carver; Timothy M Piazza; Linda A Schuler
Journal:  J Biol Chem       Date:  2010-01-15       Impact factor: 5.157

7.  Insulin-like growth factor type 1 receptor and insulin receptor isoform expression and signaling in mammary epithelial cells.

Authors:  Anne M Rowzee; Dale L Ludwig; Teresa L Wood
Journal:  Endocrinology       Date:  2009-04-30       Impact factor: 4.736

8.  Serum insulin-like growth factor (IGF)-I and IGF binding protein-3 in relation to terminal duct lobular unit involution of the normal breast in Caucasian and African American women: The Susan G. Komen Tissue Bank.

Authors:  Hannah Oh; Ruth M Pfeiffer; Roni T Falk; Hisani N Horne; Jackie Xiang; Michael Pollak; Louise A Brinton; Anna Maria V Storniolo; Mark E Sherman; Gretchen L Gierach; Jonine D Figueroa
Journal:  Int J Cancer       Date:  2018-04-01       Impact factor: 7.396

9.  IGF-I during primiparous pregnancy and maternal risk of breast cancer.

Authors:  Tianhui Chen; Annekatrin Lukanova; Kjell Grankvist; Anne Zeleniuch-Jacquotte; Marianne Wulff; Robert Johansson; Helena Schock; Per Lenner; Goran Hallmans; Goran Wadell; Paolo Toniolo; Eva Lundin
Journal:  Breast Cancer Res Treat       Date:  2009-09-02       Impact factor: 4.872

10.  Gene network and pathway analysis of bovine mammary tissue challenged with Streptococcus uberis reveals induction of cell proliferation and inhibition of PPARgamma signaling as potential mechanism for the negative relationships between immune response and lipid metabolism.

Authors:  Kasey M Moyes; James K Drackley; Dawn E Morin; Massimo Bionaz; Sandra L Rodriguez-Zas; Robin E Everts; Harris A Lewin; Juan J Loor
Journal:  BMC Genomics       Date:  2009-11-19       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.